Myomo, Inc. (NYSEAMERICAN:MYO) Shares Acquired by AIGH Capital Management LLC

AIGH Capital Management LLC increased its stake in shares of Myomo, Inc. (NYSEAMERICAN:MYO) by 21.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,381,567 shares of the company’s stock after acquiring an additional 602,719 shares during the quarter. Myomo comprises approximately 6.8% of AIGH Capital Management LLC’s holdings, making the stock its 4th largest holding. AIGH Capital Management LLC owned 11.18% of Myomo worth $21,777,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Barclays PLC acquired a new position in Myomo during the 3rd quarter valued at about $36,000. Jane Street Group LLC acquired a new stake in Myomo in the 3rd quarter valued at approximately $65,000. Thompson Davis & CO. Inc. bought a new position in Myomo in the fourth quarter valued at $181,000. Calamos Advisors LLC bought a new stake in Myomo during the fourth quarter worth about $189,000. Finally, XTX Topco Ltd bought a new position in shares of Myomo in the third quarter valued at $149,000. 44.99% of the stock is currently owned by institutional investors.

Myomo Trading Down 2.8 %

Myomo stock opened at $4.86 on Friday. Myomo, Inc. has a fifty-two week low of $2.51 and a fifty-two week high of $7.17. The company has a market cap of $147.02 million, a price-to-earnings ratio of -21.13 and a beta of 1.68.

Insider Buying and Selling

In related news, insider Harry Kovelman sold 30,000 shares of the business’s stock in a transaction dated Wednesday, March 12th. The stock was sold at an average price of $5.50, for a total value of $165,000.00. Following the sale, the insider now directly owns 97,973 shares in the company, valued at approximately $538,851.50. The trade was a 23.44 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Thomas F. Kirk acquired 7,400 shares of Myomo stock in a transaction on Thursday, March 13th. The shares were bought at an average cost of $5.00 per share, for a total transaction of $37,000.00. Following the completion of the purchase, the director now directly owns 255,933 shares of the company’s stock, valued at $1,279,665. The trade was a 2.98 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 4.54% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research firms have issued reports on MYO. Alliance Global Partners reissued a “buy” rating on shares of Myomo in a report on Tuesday, March 11th. Ascendiant Capital Markets lifted their price target on Myomo from $9.00 to $11.00 and gave the company a “buy” rating in a research note on Monday, March 17th. Craig Hallum raised their target price on shares of Myomo from $9.00 to $11.00 and gave the company a “buy” rating in a research report on Tuesday, March 11th. Finally, HC Wainwright lifted their price target on shares of Myomo from $7.50 to $9.50 and gave the stock a “buy” rating in a report on Wednesday, March 12th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $9.75.

Myomo Company Profile

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.